Skip to main content

Table 8 Rate of antibiotic Use in the IFNα1b group and the control group (%)

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

IFNα1b GroupControl GroupIFNα1b GroupControl Group
Use of Item antibiotics5 (6.6%)8 (9.2%)5 (7.2%)7 (8.5%)
Use of antibiotics71 (93.4%)79 (90.8%)64 (92.8%)75 (91.5%)
P0.745 1.000